Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004; 6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 2 Antonella Surbone, MD, PhD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):10-15. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
Case and Commentary Jan 2006 Breast Cancer Screening, Commentary 1 Heidi Malm, PhD and Gerald W. Chodak, MD Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis. Virtual Mentor. 2006; 8(1):7-10. doi: 10.1001/virtualmentor.2006.8.1.ccas1-0601.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004; 6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.